EX-99.2 3 exhibit_99-2.htm EXHIBIT 99.2

Exhibit 99.2
 
Financial Information for the Three Months and Six Months Ended June 30, 2024 and 2023 of Kenon and OPC and
 
Reconciliation of Certain non-IFRS Financial Information

Table of Contents




Appendix A

Summary Kenon consolidated financial information

Kenon Holdings Ltd. and its subsidiaries
Consolidated Statements of Financial Position (Unaudited)

   
June 30,
   
December 31,
 
   
2024
   
2023
 
   
$ millions
 
Current assets
           
Cash and cash equivalents
   
586
     
697
 
Short-term deposits and restricted cash
   
1
     
1
 
Trade receivables
   
96
     
68
 
Short-term derivative instruments
   
4
     
3
 
Other investments
   
164
     
216
 
Other current assets
   
97
     
111
 
Total current assets
   
948
     
1,096
 
Non-current assets
               
Investment in ZIM (associated company)
   
-
     
-
 
Investment in OPC’s associated companies
   
708
     
703
 
Long-term restricted cash
   
15
     
16
 
Long-term derivative instruments
   
16
     
14
 
Deferred taxes, net
   
10
     
16
 
Property, plant and equipment, net
   
1,771
     
1,715
 
Intangible assets, net
   
311
     
321
 
Long-term prepaid expenses and other non-current assets
   
49
     
52
 
Right-of-use assets, net
   
166
     
175
 
Total non-current assets
   
3,046
     
3,012
 
Total assets
   
3,994
     
4,108
 
Current liabilities
               
Current maturities of loans from banks and others
   
101
     
170
 
Trade and other payables
   
198
     
182
 
Short-term derivative instruments
   
2
     
2
 
Current maturities of lease liabilities
   
7
     
5
 
Total current liabilities
   
308
     
359
 
Non-current liabilities
               
Long-term loans from banks and others
   
891
     
906
 
Debentures
   
467
     
454
 
Deferred taxes, net
   
130
     
137
 
Other non-current liabilities
   
151
     
110
 
Long-term derivative instruments
   
17
     
16
 
Long-term lease liabilities
   
54
     
56
 
Total non-current liabilities
   
1,710
     
1,679
 
Total liabilities
   
2,018
     
2,038
 
Equity
               
Share capital
   
50
     
50
 
Translation reserve
   
(7
)
   
(4
)
Capital reserve
   
67
     
70
 
Accumulated profit
   
1,007
     
1,087
 
Equity attributable to owners of the Company
   
1,117
     
1,203
 
Non-controlling interests
   
859
     
867
 
Total equity
   
1,976
     
2,070
 
Total liabilities and equity
   
3,994
     
4,108
 


 
Kenon Holdings Ltd. and its subsidiaries
Consolidated Statements of Profit or Loss (Unaudited)
 
   
For the six months ended
June 30,
   
For the three months ended
June 30,
 
   
2024
   
2023
   
2024
   
2023
 
   
$ millions
   
$ millions
 
Revenue
   
355
     
312
     
181
     
165
 
Cost of sales and services (excluding depreciation and amortization)
   
(247
)
   
(232
)
   
(129
)
   
(129
)
Depreciation and amortization
   
(42
)
   
(30
)
   
(22
)
   
(17
)
Gross profit
   
66
     
50
     
30
     
19
 
Selling, general and administrative expenses
   
(43
)
   
(47
)
   
(22
)
   
(23
)
Other (expenses)/income, net
   
(7
)
   
(1
)
   
1
     
(2
)
Operating profit
   
16
     
2
     
9
     
(6
)
Financing expenses
   
(51
)
   
(32
)
   
(31
)
   
(18
)
Financing income
   
20
     
24
     
8
     
11
 
Financing expenses, net
   
(31
)
   
(8
)
   
(23
)
   
(7
)
Gains/(losses) related to ZIM
   
111
     
(1
)
   
111
     
-
 
Dividend income
   
6
     
-
     
6
     
-
 
Share in profit/(losses) of associated companies, net
                               
-          ZIM
   
-
     
(43
)
   
-
     
(31
)
-          OPC’s associated companies
   
23
     
28
     
4
     
4
 
Profit/(loss) before income taxes
   
125
     
(22
)
   
107
     
(40
)
Income tax expense
   
(8
)
   
(10
)
   
-
     
3
 
Profit/(loss) for the period
   
117
     
(32
)
   
107
     
(37
)
Attributable to:
                               
Kenon’s shareholders
   
121
     
(37
)
   
112
     
(30
)
Non-controlling interests
   
(4
)
   
5
     
(5
)
   
(7
)
Profit/(loss) for the period
   
117
     
(32
)
   
107
     
(37
)
                                 
Basic/diluted profit/(loss) per share attributable to Kenon’s shareholders (in dollars):
                               
Basic/diluted profit/(loss) per share
   
2.28
     
(0.70
)
   
2.13
     
(0.56
)
 
A - 2


Kenon Holdings Ltd. and its subsidiaries
Consolidated Statements of Cash Flows (Unaudited)

   
For the six months ended
June 30,
 
   
2024
   
2023
 
   
$ millions
 
Cash flows from operating activities
           
Profit for the period
   
117
     
(32
)
Adjustments:
               
Depreciation and amortization
   
46
     
38
 
Financing expenses, net
   
31
     
8
 
Gains related to ZIM
   
(111
)
   
1
 
Share in (profit)/losses of associated companies, net
   
(23
)
   
15
 
Share-based payments
   
3
     
5
 
Other expenses, net
   
8
     
-
 
Income tax expense
   
8
     
10
 
     
79
     
45
 
Change in trade and other receivables
   
(28
)
   
4
 
Change in trade and other payables
   
24
     
(11
)
Cash generated from operating activities
   
75
     
38
 
Income taxes paid, net
   
(1
)
   
(1
)
Dividend received from associate companies, net
   
13
     
152
 
Net cash provided by operating activities
   
87
     
189
 

A - 3

 
 
Kenon Holdings Ltd. and its subsidiaries
Consolidated Statements of Cash Flows (Unaudited), continued

   
For the six months ended
June 30,
 
   
2024
   
2023
 
   
$ millions
 
Cash flows from investing activities
           
Short-term deposits and restricted cash, net
   
(1
)
   
30
 
Short-term collaterals deposits, net
   
2
     
20
 
Investment in long-term deposits, net
   
1
     
-
 
Investment in associated companies, less cash acquired
   
(8
)
   
(2
)
Acquisition of subsidiary, less cash acquired
   
-
     
(250
)
Acquisition of property, plant and equipment
   
(137
)
   
(139
)
Acquisition of intangible assets
   
-
     
(5
)
Proceeds from sale of interest in ZIM
   
111
     
-
 
Proceeds from distribution from associated company
   
-
     
2
 
Proceeds from sale of other investments
   
56
     
139
 
Purchase of other investments
   
-
     
(50
)
Long-term advance deposits
   
-
     
(7
)
Long-term loans to an associate
   
-
     
(24
)
Interest received
   
13
     
12
 
Proceeds from transactions in derivatives, net
   
-
     
2
 
Net cash provided by/(used in) investing activities
   
37
     
(272
)
                 
Cash flows from financing activities
               
Repayment of long-term loans, debentures and lease liabilities
   
(66
)
   
(124
)
Repayment of short-term loans, net
   
(55
)
   
-
 
Investments of holders of non-controlling interests in the capital of a subsidiary
   
-
     
129
 
Investment of non-controlling interest in subsidiary
   
9
     
54
 
Tax equity investment
    41
      -
 
Proceeds from issuance of debentures, less issuance expenses
   
52
     
267
 
Proceeds from long-term loans
   
16
     
1
 
Proceeds from derivative financial instruments, net
   
1
     
(14
)
Costs paid in advance in respect of taking out of loans
   
-
     
(5
)
Dividend paid
   
(201
)
   
(150
)
Interest paid
   
(31
)
   
(16
)
Net cash (used in)/provided by financing activities
   
(234
)
   
142
 
                 
(Decrease)/increase in cash and cash equivalents
   
(110
)
   
59
 
Cash and cash equivalents at beginning of the year
   
697
     
535
 
Effect of exchange rate fluctuations on balances of cash and cash equivalents
   
(1
)
   
(4
)
Cash and cash equivalents at end of the period
   
586
     
590
 

A - 4


Information regarding reportable segments
 
Information regarding activities of the reportable segments are set forth in the following table.
 
 
 
For the six months ended June 30, 2024
 
   
OPC Israel
   
CPV Group
   
ZIM
   
Other
   
Consolidated Results
 
   
$ millions
 
Revenue          
   
291
     
64
     
-
     
-
     
355
 
Depreciation and amortization
   
(33
)
   
(13
)
   
-
     
-
     
(46
)
Financing income          
   
4
     
2
     
-
     
14
     
20
 
Financing expenses          
   
(32
)
   
(15
)
   
-
     
(4
)
   
(51
)
Gains related to ZIM
   
-
     
-
     
111
     
-
     
111
 
Share in profit of associated companies
   
-
     
23
     
-
     
-
     
23
 
Profit before taxes          
   
3
     
1
     
111
     
10
     
125
 
Income tax expense          
   
(7
)
   
-
     
-
     
(1
)
   
(8
)
(Loss)/profit for the period
   
(4
)
   
1
     
111
     
9
     
117
 

 
 
For the six months ended June 30, 2023
 
   
OPC Israel
   
CPV Group
   
ZIM
   
Other
   
Consolidated Results
 
   
$ millions
 
Revenue          
   
278
     
34
     
-
     
-
     
312
 
Depreciation and amortization
   
(31
)
   
(7
)
   
-
     
-
     
(38
)
Financing income
   
8
     
3
     
-
     
13
     
24
 
Financing expenses          
   
(25
)
   
(6
)
   
-
     
(1
)
   
(32
)
Loss related to ZIM          
   
-
     
-
     
(1
)
   
-
     
(1
)
Share in profit of associated companies
   
-
     
28
     
(43
)
   
-
     
(15
)
Profit/(loss) before taxes
   
8
     
7
     
(44
)
   
7
     
(22
)
Income tax expense          
   
-
     
(3
)
   
-
     
(7
)
   
(10
)
Profit/(loss) for the period
   
8
     
4
     
(44
)
   
-
     
(32
)

A - 5


 
 
For the three months ended June 30, 2024
 
   
OPC Israel
   
CPV Group
   
ZIM
   
Other
   
Consolidated Results
 
   
$ millions
 
Revenue          
   
146
     
35
     
-
     
-
     
181
 
Depreciation and amortization
   
(17
)
   
(7
)
   
-
     
-
     
(24
)
Financing income          
   
1
     
1
     
-
     
6
     
8
 
Financing expenses          
   
(17
)
   
(8
)
   
-
     
(6
)
   
(31
)
Gains related to ZIM
   
-
     
-
     
111
     
-
     
111
 
Share in profit of associated companies
   
-
     
4
     
-
     
-
     
4
 
(Loss)/profit before taxes
   
(1
)
   
(6
)
   
111
     
3
     
107
 
Income tax expense          
   
(1
)
   
1
     
-
     
-
     
-
 
(Loss)/profit for the period
   
(2
)
   
(5
)
   
111
     
3
     
107
 

 
 
For the three months ended June 30, 2023
 
   
OPC Israel
   
CPV Group
   
ZIM
   
Other
   
Consolidated Results
 
   
$ millions
 
Revenue          
   
147
     
18
     
-
     
-
     
165
 
Depreciation and amortization
   
(19
)
   
(4
)
   
-
     
-
     
(23
)
Financing income          
   
2
     
1
     
-
     
8
     
11
 
Financing expenses          
   
(15
)
   
(4
)
   
-
     
1
     
(18
)
Share in profit of associated companies
   
-
     
4
     
(31
)
   
-
     
(27
)
(Loss)/profit before taxes
   
(6
)
   
(8
)
   
(31
)
   
5
     
(40
)
Income tax expense          
   
2
     
1
     
-
     
-
     
3
 
(Loss)/profit for the period
   
(4
)
   
(7
)
   
(31
)
   
5
     
(37
)

A - 6


Appendix B
 
Summary of OPC consolidated financial information
 
OPC’s Consolidated Statements of Profit or Loss (Unaudited)
 
   
For the six months ended
June 30,
   
For the three months ended
June 30,
 
   
2024
   
2023
   
2024
   
2023
 
   
$ millions
   
$ millions
 
Revenue
   
355
     
312
     
181
     
165
 
Cost of sales (excluding depreciation and amortization)
   
(247
)
   
(232
)
   
(129
)
   
(129
)
Depreciation and amortization
   
(42
)
   
(30
)
   
(24
)
   
(17
)
Gross profit
   
66
     
50
     
28
     
19
 
Selling, general and administrative expenses
   
(38
)
   
(42
)
   
(17
)
   
(21
)
Other (expenses)/income
   
(7
)
   
(1
)
   
1
     
-
 
Operating profit/(loss)
   
21
     
7
     
12
     
(2
)
Financing expenses
   
(47
)
   
(31
)
   
(25
)
   
(19
)
Financing income
   
6
     
11
     
2
     
3
 
Financing expenses, net
   
(41
)
   
(20
)
   
(23
)
   
(16
)
Share in profit of associated companies, net
   
23
     
28
     
4
     
4
 
Profit/(loss) before income taxes
   
4
     
15
     
(7
)
   
(14
)
Income tax (expense)/benefit
   
(7
)
   
(3
)
   
-
     
3
 
(Loss)/profit for the period
   
(3
)
   
12
     
(7
)
   
(11
)
                                 
Attributable to:
                               
Equity holders of the company
   
1
     
11
     
(4
)
   
(6
)
Non-controlling interest
   
(4
)
   
1
     
(3
)
   
(5
)
(Loss)/profit for the period
   
(3
)
   
12
     
(7
)
   
(11
)


 
Summary Data from OPC’s Consolidated Statement of Cash Flows (Unaudited)

 
 
For the six months ended
June 30,
   
For the three months ended
June 30,
 
   
2024
   
2023
   
2024
   
2023
 
   
$ millions
   
$ millions
 
Cash flows provided by operating activities
   
89
     
45
     
17
     
17
 
Cash flows used in investing activities
   
(139
)
   
(369
)
   
(71
)
   
(295
)
Cash flows (Used in)/provided by financing activities
   
(34
)
   
307
     
21
     
86
 
Decrease in cash and cash equivalents
   
(84
)
   
(17
)
   
(33
)
   
(192
)
Cash and cash equivalents at end of the period
   
192
     
221
     
192
     
221
 

Summary Data from OPC’s Consolidated Statement of Financial Position (Unaudited)
 
 
 
As at
 
 
 
June 30,
2024
   
December 31, 2023
 
 
 
$ millions
 
Total financial liabilities1
   
1,458
     
1,530
 
Total monetary assets2
   
209
     
278
 
Investment in associated companies
   
708
     
703
 
Total equity attributable to the owners
   
1,050
     
1,061
 
Total assets
   
3,441
     
3,479
 
 
1.
Including loans from banks and others and debentures
2.
Including cash and cash equivalents, term deposits and restricted cash
 
B - 2


Appendix C
 
Definition of OPC’s Adjusted EBITDA and Adjusted EBITDA (including proportionate share in EBITDA of associated companies) and non-IFRS reconciliation
 
This press release, including the financial tables, presents OPC’s Adjusted EBITDA (including proportionate share in EBITDA of associated companies), which is non-IFRS financial measures.
 
OPC’s Adjusted EBITDA (including proportionate share in EBITDA of associated companies) is defined as net profit/(loss) before depreciation and amortization, financing expenses, net, share of depreciation and amortization and financing expenses, net, included within share of profit of associated companies, net, income tax expense, changes in net expenses, not in the ordinary course of business and/or of a non-recurring nature, other income/(expenses) and share of changes in fair value of derivative financial instruments. Adjusted EBITDA (including proportionate share in EBITDA of associated companies) is not recognized under IFRS as a measure of financial performance and should not be considered as a substitute for net profit or loss, cash flow from operations or other measures of operating performance determined in accordance with IFRS. Adjusted EBITDA (including proportionate share in EBITDA of associated companies) is not intended to represent funds available for dividends or other discretionary uses because those funds may be required for debt service, capital expenditures, working capital and other commitments and contingencies. There are limitations that impair the use of Adjusted EBITDA (including proportionate share in EBITDA of associated companies) as a measures of OPC’s profitability since it does not take into consideration certain costs and expenses that result from OPC’s business that could have a significant effect on net profit, such as financial expenses, taxes, and depreciation and amortization.

OPC believes that the disclosure of Adjusted EBITDA (including proportionate share in EBITDA of associated companies) provides useful information to investors and financial analysts in their review of OPC’s, its subsidiaries’, and its associated companies’ operating performance and in the comparison of such operating performance to the operating performance of other companies in the same industry or in other industries that have different capital structures, debt levels and/or income tax rates.
 
Set forth below is a reconciliations of OPC’s profit/(loss) to Adjusted EBITDA (including proportionate share in EBITDA of associated companies) for the periods presented. Other companies may calculate Adjusted EBITDA (including proportionate share in EBITDA of associated companies) differently, and therefore this presentation of Adjusted EBITDA (including proportionate share in EBITDA of associated companies) may not be comparable to other similarly titled measures used by other companies.

   
For the three months
ended June 30,
 
 
 
2024
   
2023
 
 
 
$ millions
 
Loss for the period
   
(7
)
   
(11
)
Depreciation and amortization
   
24
     
23
 
Financing expenses, net
   
23
     
16
 
Share of depreciation and amortization and financing expenses, net, included within share of profit/(losses) of associated companies, net
   
26
     
20
 
Income tax expense
   
-
     
(3
)
Share of changes in fair value of derivative financial instruments
   
-
     
(2
)
Changes in net expenses, not in the ordinary course of business and/or of a non-recurring nature
   
-
     
3
 
Other expenses
   
-
     
1
 
Adjusted EBITDA (including proportionate share in EBITDA of associated companies)
   
66
     
47
 



Appendix D
 
Summary Financial Information of OPC’s Subsidiaries
 
The tables below set forth debt, cash and cash equivalents, and debt service reserves for OPC’s subsidiaries as of June 30, 2024 and December 31, 2023 (in $ millions):

As at June 30, 2024
 
OPC Energy
   
OPC-Rotem
   
OPC-Hadera
   
OPC-Tzomet
   
OPC-Gat
   
CPV Keenan
   
Others
   
Total
 
 
                                               
D  Debt (including accrued interest)
   
54
     
-
     
171
     
296
     
115
     
76
     
155
     
867
 
Cash and cash equivalents (including restricted cash used for debt service)
   
43
     
2
     
26
     
25
     
3
     
-
     
94
     
193
 
Derivative financial instruments for hedging principal and/or interest
   
-
     
-
     
10
     
-
     
-
     
5
     
(1
)
   
14
 
Net debt*
   
11
     
2
     
135
     
271
     
112
     
71
     
59
     
661
 

As at December 31, 2023
 
OPC Energy
   
OPC-Rotem
   
OPC-Hadera
   
OPC-Tzomet
   
OPC-Gat
   
CPV Keenan
   
Others
   
Total
 
 
                                               
D  Debt (including accrued interest)
   
56
     
-
     
177
     
306
     
120
     
79
     
161
     
899
 
Cash and cash equivalents (including restricted cash used for debt service)
   
44
     
2
     
27
     
26
     
3
     
-
     
93
     
195
 
Derivative financial instruments for hedging principal and/or interest
   
-
     
-
     
10
     
-
     
-
     
5
     
(1
)
   
14
 
Net debt*
   
12
     
(2
)
   
140
     
280
     
116
     
73
     
69
     
688
 

*Net debt is defined as debt minus cash and cash equivalents and deposits and restricted cash.



Appendix E
 
Definition of ZIM’s Adjusted EBITDA and non-IFRS reconciliation

This press release presents ZIM’s Adjusted EBITDA, which is a non-IFRS financial measure.
 
ZIM defines Adjusted EBITDA for each period as profit/(loss) adjusted to exclude depreciation and amortization, financial expenses/(income), net, and income tax expense / (benefits), in order to reach EBITDA, and further adjusted to exclude impairments of assets, non-cash charter hire expenses, capital gains/(losses) beyond the ordinary course of business and expenses related to legal contingencies. Adjusted EBITDA is not recognized under IFRS as a measure of financial performance and should not be considered as a substitute for net profit or loss, cash flow from operations or other measures of operating performance determined in accordance with IFRS. Adjusted EBITDA is not intended to represent funds available for dividends or other discretionary uses because those funds may be required for debt service, capital expenditures, working capital and other commitments and contingencies. There are limitations that impair the use of Adjusted EBITDA as a measure of ZIM’s profitability since it does not take into consideration certain costs and expenses that result from ZIM’s business that could have a significant effect on net profit, such as financial expenses, taxes, and depreciation and amortization. 

ZIM believes that the disclosure of Adjusted EBITDA enables the comparison of operating performance between periods on a consistent basis. This measure should not be considered in isolation, or as a substitute for operating income, any other performance measure, or cash flow data, which were prepared in accordance with IFRS as measures of profitability or liquidity. In addition, non-IFRS financial measures may not be comparable to similarly titled measures reported by other companies, due to differences in the way these measures are calculated.
 
Set forth below is a reconciliation of ZIM’s profit/(loss) to Adjusted EBITDA for the periods presented(*).

   
For the three months ended June 30,
 
 
 
2024
   
2023
 
 
 
$ millions
 
Profit/(loss) for the period
   
373
     
(213
)
Depreciation and amortization
   
278
     
422
 
Financing expenses, net
   
93
     
104
 
Income tax expense/(benefits)
   
2
     
(59
)
EBITDA
   
746
     
254
 
Capital loss, beyond the ordinary course of business
   
-
     
21
 
Expenses related to legal contingencies
   
20
     
-
 
Adjusted EBITDA
   
766
     
275
 

* The table above may contain slight summation differences due to rounding.